Showing 1 posts of 1 posts found.
Eli Lilly has announced a project, known as Lilly 30×30, which is a five-year, $90 million investment to improve access …
From lab breakthrough to NHS treatment: Getting innovative therapies to patients
Five Facts about NHS and primary care
Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.
AI in pharma: From lab development to patient impact
Back to basics: X-ray inspection in pharmaceutical and medical device production